France Vaccine Industry Outlook 2022 - 2026

Key Market Indicators

French Vaccination Coverage is set to reach 95% of children aged one year old by 2026, falling by 0.2 points year on year on average. This follows a period of stable coverage since 1985. Meanwhile, French vaccine imports are predicted to drop to $1.1 billion in 2026, down 0.5% year on year. This follows a decrease of 1.6% year on year since 1999, placing France fifth in 2021. The US, UK and Germany respectively ranked second, third and fourth. On the other hand, French vaccine exports are expected to climb to $4.7 billion in 2026, growing 1.9% year on year on average. This follows an increase of 5.4% year on year since 1999, putting France in fourth place in 2021. Ireland, the UK and France respectively took the second, third and fourth spots.

France Vaccine Market Data and Forecasts

Improve your Knowledge with the latest Indicators and Trends

• Pharmaceutical Innovation: Exploring Synergies in Antibiotics and Antibody Drugs Development

  Innovation in the pharmaceutical sector, specifically within antibiotics and antibody drugs, is fuelled by a multitude of factors. Increasing antimicrobial resistance necessitates the development of new antibiotics, while complex diseases like cancer and autoimmune disorders demand advanced immunotherapies. Continuous advances in technology and science also play a crucial role, alongside...

  Discover more insights

• Vaccine Market Insights: Exploring Trends in Pneumococcal and Meningococcal Immunization

  The pneumococcal vaccine market is predominantly driven by the escalating global burden of pneumococcal diseases, including pneumonia, meningitis, and sepsis. With pneumococcal bacteria as a leading cause of vaccine-preventable deaths worldwide, policymakers and health organizations are ramping up immunization drives, amplifying vaccine demand. Furthermore, the introduction of innovative vaccine variants—quelling...

  Discover more insights

• Vaccines Market: Insights into Global Trends and Emerging Forecast Practices

  Worldwide, the vaccine market is propelled forward by a combination of public health imperatives, advances in vaccine development technologies, and various market incentives. Increased rate of infectious diseases boosts the demand for vaccines, thereby expanding the markets. The swift focus on the development and distribution of COVID-19 vaccines is a...

  Discover more insights

• Travel Vaccines Market: A Comprehensive Review on Growth, Trends, and Forecast Opportunities

  The market for travel vaccines is fundamentally driven by the swelling global mobility and increased exposure to infectious diseases in developing countries. Effectively, as more people venture overseas, either due to recreational, educational, or business reasons, there is an escalated demand for specialized vaccinations. This market dynamic also reflects the...

  Discover more insights

• Global Health Initiatives: The Transformative Impact and Industry Dynamics of Dengue Vaccines

  The dengue vaccine market unravels unparalleled potential towards altering the global public health landscape. The vaccine, formulated to combat one of the most common mosquito-borne illnesses worldwide, bears significant potential to diminish morbidity and mortality. Additionally, the proliferation of such vaccines could catalyze a substantial reduction in healthcare expenses linked...

  Discover more insights